Estudio del efecto de la negación en la detección de interacciones entre fármacos by Bokharaeian, Behrouz et al.
Extracting Drug-Drug Interaction
from Text Using Negation Features
Estudio del efecto de la negacio´n en la deteccio´n de interacciones entre
fa´rmacos
Behrouz Bokharaeian, Alberto Dı´az
NIL Group








Resumen: La extraccio´n de relaciones entre entidades es una tarea muy impor-
tante dentro del procesamiento de textos biome´dicos. Se han desarrollado muchos
algoritmos para este propo´sito aunque so´lo unos pocos han estudiado el tema de
las interacciones entre fa´rmacos. En este trabajo se ha estudiado el efecto de la
negacio´n para esta tarea. En primer lugar, se describe co´mo se ha extendido el
corpus DrugDDI con anotaciones sobre negaciones y, en segundo lugar, se muestran
una serie de experimentos en los que se muestra que tener en cuenta el efecto de
la negacio´n puede mejorar la deteccio´n de interacciones entre fa´rmacos cuando se
combina con otros me´todos de extraccio´n de relaciones.
Palabras clave: Interacciones entre fa´rmacos, negacio´n, funciones kernel, ma´quinas
de vectores de soporte, funciones kernel.
Abstract: Extracting biomedical relations from text is an important task in
BioMedical NLP. There are several systems developed for this purpose but the ones
on Drug-Drug interactions are still a few. In this paper we want to show the ef-
fectiveness of negation features for this task. We firstly describe how we extended
the DrugDDI corpus by annotating it with the scope of negation, and secondly we
report a set of experiments in which we show that negation features provide benefits
for the detection of drug-drug interactions in combination with some simple relation
extraction methods.
Keywords: Drug-Drug interaction, Negation, Support vector machines, kernel-
based methods
1. Introduction
A drug-drug interaction (DDI) occurs when
one drug affects the level or activity of an-
other drug, this may happen, for instance, in
the case of drug concentrations. This interac-
tion can result on decreasing its effectiveness
or possibly altering its side effects that may
even the cause of health problems to patients
(Stockley, 2007).
There is a great amount of DDI databases
and this is why health care experts have dif-
ficulties to be kept up-to-date of everything
published on drug-drug interactions. This
fact means that the development of tools for
automatically extracting DDIs from biomed-
ical resources is essential for improving and
updating the drug knowledge and databases.
There are also many systems on the ex-
traction of biomedical relations from text;
however the research on studying the effect
of negation in biomedical relation extraction
is still limited. On the other hand, nega-
tion is very common in clinical texts and
it is one of the main causes of making er-
rors in automated indexing systems (Chap-
man et al., 2001); the medical personnel is
mostly trained to include negations in their
reports. Particularly when we are detect-
ing the interaction between drugs, the pres-
ence of negations can produce false positives
classifications, for instance, the sentence Co-
administration of multiple doses of 10 mg
of lenalidomide had no effect on the single
dose pharmacokinetics of R- and S- warfarin
a DDI between lenalidomide and warfarin
could be detected as a practicable fact if
negation is not taken into account. We there-
fore believe that detecting the words that
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are affected by negations may be an essen-
tial part in most biomedical text mining tasks
that try to obtain automatically the accurate
knowledge from textual data.
In order to avoid errors derived of us-
ing automatic negation detection algorithms
such as NegEx (Amini et al., 2011), we anno-
tated a DDI corpus - previously developed-
with the scope of negations. The corpus
is called DrugDDI corpus (Segura-Bedmar
et al., 2011b), and it was developed for
the Workshop on Drug-Drug Interaction Ex-
traction (Segura-Bedmar et al., 2011a) that
took place in 2011 in Huelva, Spain. The
DrugDDI corpus contains 579 documents ex-
tracted from the DrugBank database. We an-
alyzed the corpus and we annotated the sen-
tences within with the scope of negation in
order to find the effect of negation features in
the detection of DDIs. We annotated it using
the same guidelines of the BioScope corpus
(Vincze et al., 2008), that is, we annotated
cues and scopes affected by negation state-
ments into sentences in a linear format.
For detecting the DDIs we used a fast ver-
sion of a support vector machine (henceforth,
SVM) classifier with a linear kernel based on
a bag of words (henceforth, BOW) represen-
tation obtained from the extracted features.
We carried out some experiments with dif-
ferent kernels (global context, subtree, short-
est path), with and without negation infor-
mation. The results presented in this paper
show that negation features can improve the
performance of relation extraction methods.
The rest of the paper is structured as
follows. In Section 2 we discuss previous
related work about biomedical relation ex-
traction and relevant information about the
DrugDDI corpus. In Section 3 we explain
how we annotated the corpus with the scope
of negation. In Section 4 we explain how we
used the obtained information from negation
tags to improve the DDI detection task. In
Section 5 we discuss the results obtained. Fi-
nally, in Section 6, we show our conclusions
and suggestions for future work.
2. Related work
In this Section we describe the DrugDDI cor-
pus and we present some related work on
kernel-based relation extraction.
2.1. DrugDDI corpus
There are some annotated corpora that
were developed with the intention of study-
ing biomedical relation extraction, such as,
Aimed (Bunesu et al., 2005), LLL (Nedellec
et al., 2005), BioCreAtIvE-PPI (Krallinger
et al., 2008) on protein-protein interactions
(PPI) and DrugDDI (Segura-Bedmar et al.,
2011b), on drug-drug interactions. In par-
ticular, the DrugDDI corpus is the first an-
notated corpus on the phenomenon of inter-
actions among drugs and it is the one that
we used for our experiments. It was de-
signed with the intention of encouraging the
NLP community to conduct further research
on this type of interactions. The DrugBank
database (Wishart et al., 2008) was used as
source to develop this corpus. This database
contains unstructured textual information on
drugs and their interactions.
The DrugDDI corpus is available in two
different formats: (i) the first one con-
tains the information provided by MMTX
(Aronson, 2001) and the unified format
adapted from PPI corpora format proposed
in (Pyysalo et al., 2008). The unified XML
format (see Figure 1) does not contain any
linguistic information; it only provides the
plain text sentences, their drugs and their in-
teractions. Each entity (drug) includes ref-
erence (origId) to the sentence identifier in
the MMTX format corpus. For each sen-
tence contained in the unified format, the
annotations correspond to all the drugs enti-
ties and the possible DDI candidate pair that
represents the interaction. Each DDI candi-
date pair is represented as a pair ID node in
which the identifiers of the interacting drugs
are registered on its e1 and e2 attributes. If
the pair is a DDI, the interaction attribute
is set to true, otherwise this attribute is set
to false. Table 1 shows related statistics of




Nowadays, there are many systems developed
for extracting biomedical relations from text
that can be categorized in (i) feature based
and (ii) kernel-based approaches. Feature-
based approaches transform the context of
entities into a set of features; this set is
used to train a data-driven algorithm. On
the other hand, kernel-based approaches are
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Sentences with at least two drug 3,775
Sentences with at least one DDI 2,044
Sentences with no DDI 3,762
Candidate drug pairs 30,757
Positive interactions 3,160
Negative interactions 27,597
Table 1: Basic statistics for the DrugDDI
corpus.
based on similarity functions. This idea pro-
vides the option of checking structured rep-
resentations, such as parse trees and comput-
ing the similarity between different represen-
tations directly. Combing kernel based and
feature based approaches were investigated
by Thomas et al. (2011), they developed a
voting system (based on majority) that ben-
efits from the outcomes of several methods.
So far, the sequence and tree kernels are
the ones that have shown a superior perfor-
mance for the detection of biomedical rela-
tions from text (Bunesu et al., 2005). In
particular, global context kernel, subtree and
shortest path kernels are three important ker-
nel methods that were applied successfully
for biomedical relation extraction task. For
instance, Giuliano et al. (2005) applied by
considering three different patterns and they
calculated the similarity between two sen-
tences by computing common n-grams of two
different patterns.
The shortest path kernel (Bunescu y
Mooney, 2005) uses the shortest path be-
tween two entities (or drugs) in a phrase
structure tree. The subtree kernel (Mos-
chitti, 2006) counted the number of common
subtrees in whole parse trees by comparing
two different sentences. Moreover, a com-
parative survey about different kernel-based
approaches and their performances can be
found in (Frunza y Inkpen, 2010).
More recent research on tree kernels were
carried out by Guodong et al. (2010). They
introduced a ”context-sensitive“ convolution
tree kernel, which specifies both ”context-
free“ and ”context-sensitive“ sub-trees by
traversing the paths of their ancestor nodes
as their contexts to capture structural infor-
mation in the tree structure. Another mo-
tivating work was reported by Chen et al.
(2011), that presented a proteing-protein in-
teraction pair extractor, it consists on a SVM
classifier that exploits a linear kernel with a
complete set of features.
Finally, Simo˜es et al. (2013) introduced
an approach for Relation Extraction (RE)
based on labeled graph kernels, they pro-
posed an implementation of a random walk
kernel (Neuhaus y Bunke, 2006) that mainly
explores two characteristics: (i) the words be-
tween the candidate entities and (ii) the com-
bined information from different sources.
3. Annotating the DrugDDI
corpus with negations
We followed the Bioscope guidelines in order
to annotate the corpus (Vincze et al., 2008).
The main idea is based in the detection of a
set of negation cues, like ’no’ or ’not’. Af-
ter this, the scope of the cue is calculated
based on its syntactic context. There are
several systems that annotate the scope of
negation, in our approach we used the one
published by Ballesteros et al. (Ballesteros et
al., 2012), which is publicly available,1 rule-
based system that works on biomedical litera-
ture (Bioscope) and the input is just the sen-
tence without any required annotation, which
serves very well for our purposes.
We used as input all the sentences of the
DrugDDI corpus, containing 5,806 sentences
and 579 files. The output was therefore a
set of sentences annotated with the scope of
negation. After applying the system, we ob-
served that there were a set of 1,340 sen-
tences containing negations in the corpus,
1http://minerva.fdi.ucm.es:8888/
ScopeTagger/
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which conforms 23% of the corpus.
Taking into account that the negation
scope detection system is fully automatic, we
manually checked the outcome correcting the
annotations when needed. In order to do so,
we divided the annotated corpus in 3 different
sets that were assigned to 3 different evalu-
ators. The evaluators checked all the sen-
tences contained in each set and corrected
the sentences that contained annotation er-
rors. After this revision, a different evaluator
revised all the annotations produced by the
other 3 evaluators. Finally, we got the whole
set of 1,340 sentences (correctly) annotated
with the scope of negation.
The algorithm produced errors -according
to the evaluators- in 350 sentences from
the 1,340, including false positives matches
(there were 16 cases). Which means that 74%
of sentences was annotated correctly in an
automatic way, when considering a full scope
match. The main errors produced by the al-
gorithm were related with the processing of
passive voice sentences, commas, and copu-
lative keywords (and, or). In particular the
problem of passive voice sentences was re-
lated with the pattern It + to be + not +
past participle, which seems that it was not
captured by the system, at least in all cases.
The false positives were related with the cue
failure, which is not a negation when it is a
noun modified by an adjective, for instance,
renal failure or heart failure. In the DrugDDI
corpus these words appear always as nouns,
and therefore all of the performed annota-
tions were incorrect.
The following paragraph shows some ex-
amples and corrections made by the evalua-
tors:
Scope closed in an incorrect way con-
taining words from two different clauses
such as: Example: It is [{not} clear
whether this represents an interaction
with TIKOSYN or the presence of more
severe structural heart disease in pa-
tients on digoxin;]. The scope should be
closed in or.
Scope closed in an incorrect way in
copulative coordinated sentences: Ex-
ample: The following medications have
been administered in clinical trials with
Simulect? with [{no} increase in adverse
reactions: ATG/ALG] , azathioprine,
corticosteroids, cyclosporine, mycophe-
nolate mofetil, and muromonab-CD3.
Scope opened incorrectly in coordinated
copulative sentences: Example: In an in
vitro study, cytochrome P450 isozymes
1A2, 2A6, 2C9, 2C19, 2D6, 2E1, [and
3A4 were{not} inhibited by exposure to
cevimeline].
Some passive voice sentences were not
detected. In particular, as it is already
mentioned, sentences with the format ’It
(this and that) + finite form of to be +
not + past participle’. Example: [Con-
comitant use of bromocriptine mesylate
with other ergot alkaloids is{not} recom-
mended].
We also carried out some analysis concern-
ing the number of different cues in the corpus
and the number of different errors observed.
Table 2 shows that not and no are by far
the most frequent cues in the corpus. It can
be observed that the most problematic cue is
neither ... nor.
Cue No. MODFs Rate
Not 855 266 31.1%
No 439 58 13.2%
without 47 8 17.0%
Neither ... nor 14 12 85.7%
Absence 10 5 50%
Lack 8 1 12.5%
cannot 7 4 57.1%
Table 2: Statistics of negations cues in the
corpus and modifications for each cue in the
manual checking process.
We finally explored the sentences that are
not automatically annotated but they indeed
show a negative statement in order to find
false negatives. We looked into several nega-
tions cues that are not detected by the system
such as unaffected, unchanged or nonsignifi-
cant. We detected and corrected 75 different
sentences that belong to this problem.
Here we show some examples of false neg-
atives:
[The pharmacokinetics of naltrexone
and its major metabolite 6-beta-
naltrexol were {unaffected} following
co-administration with Acamprosate].
[Mean T max and mean plasma elimi-
nation half-life of albendazole sulfoxide
were {unchanged}].
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Monoamine Oxidase Inhibition: Line-
zolid is a reversible, [{nonselective} in-
hibitor of monoamine oxidase].
Therefore, the corpus finally contains
1,399 sentences annotated with the scope of
negation, of which 932 correspond to sen-
tences in which there are at least two drugs
mentioned. It is worth mentioning that there
are 1,731 sentences with 2 or more drug men-
tions but no DDI, and 2,044 with 2 or more
drugs and at least one interaction.
Finally, the extension of the DrugDDI cor-
pus consists of adding a new tag in the an-
notation of each sentence with the scope of
negations. Figure 3 shows an example. The
produced corpus is available for public use.2
4. DDI detection
In this Section, we explain in detail the ex-
periments we carried out by using negation
features. First, we illustrate in detail the
methods we used without negation features,
and then we present our proposed combined
negation method, see figure 4. All the experi-
ments were carried out by using the Stanford
parser3 for tokenization and constituent pars-
ing (Cer et al., 2010), and the SVMs provided
by Weka as training engine.
4.1. DDI detection without
negation features
The DDI extraction method consists of four
different processes: (1) initial prepossessing,
(2) feature extraction, (3) Bag of Words com-
putation and (4) classification. The prepro-
cessing step (1) consists of removing some
stop words and tokens, for instance remov-
ing question marks at the beginning of the
sentence. We also carried out a normaliza-
tion task for some tokens due to the usage of
different encoding and processing methods,
mainly HTML tags. In the feature extraction
step (2), we extracted three different feature
sets corresponding to different used relation
extraction methods. The feature extraction
step for global context kernel consists of ex-
tracting fore-between, between, and between-
after tokens that we mentioned in Section 2.
The feature extraction step for shortest path





of the sentence and then extracting short-
est path between two drugs in the gener-
ated parse tree. And for the subtree kernel
we also extracted all subtrees from the men-
tioned constituent parse tree. After extract-
ing features, we applied the BOW method (3)
to generate new feature sets that the SVM
classifier uses. The aim of this step is pro-
ducing a new representation of the instances
which is used in the classification step. And
finally in the classification step (4), we ap-
plied the Weka SVM classifier (Platt, 1998)
(SMO), with a linear composition of features
produced by the BOW method to detect the
interactions among drugs. The Inner product
of new features was used as kernel function
between two new representations.
4.2. DDI detection with negation
features
In this section, we explain our proposed
method that merges negation features with
the features mentioned in Section 4.1. We
divided the corpus in instances affected by
negation and instances without negation
statements. The last ones were classified in
the same way as in Section 4.1, while for
the instances with negations we added nega-
tion features to the representation. The pos-
itive instances were classified in the same
way as previous approaches but the sentences
containing negations were categorized using
negation features in addition to the other pre-
vious features. As in previous subsection, the
combined method for instances containing
negations consists of 4 steps. After a simple
preprocessing step we carried out a feature
extraction process. In this step, we generated
six negation features in addition to three fea-
ture sets corresponding to global context ker-
nel (GCK), Shortest Path and Subtree kernel
methods. Negation feature consists of tokens
inside the negation scope, left side tokens
outside of the negation scope and right side
tokens, and the negation cue tokens, negation
cue, and position of open and closed negation
scope. For instance in the sentence shown in
Figure 3: tokens inside brackets create mid-
dle scope features, right side tokens construct
right features and tokens in the left side of the
negation scope form left scope features. As
in the previous subsection, we used a BOW
method to convert negation string features to
word features. Finally, the new feature set is
used to classify the drug-drug interactions by
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Figure 2: A sentence annotated with the Scope of Negation in our version of the DrugDDI
corpus.
making use of the Weka SVM.
Figure 3: Left, middle and right side scope
and negation cue in a negative sentence.
In summation, our approach is a feature
based method that uses a bag of word kernel
utilizing basic features to compute simple ba-
sic kernels and negation features. We applied
a fast implementation of the support vector
machine provided in Weka, which uses se-
quential minimal optimization. By carrying
out some experiments we also limited the size
of the words in each feature bag in the BOW
approach to 1000 words per feature class.
Figure 4: The different processes followed
by our proposed approach.
5. Evaluation
5.1. Evaluation Setup
In order to demonstrate the improvements
provided by using negation features, our ex-
periments consisted of a 10-fold cross valida-
tion over the training part of the DrugDDI
corpus. Therefore, our results are not di-
rectly comparable to the ones provided in
the DDI challenge (Segura-Bedmar et al.,
2011a). The training DrugDDI corpus con-
tains 437 documents extracted from Drug-
Bank database. It consists of 4267 sentences
with average of 9.8 sentences per document
and 25,209 instances with 2,402 interactions
between different drugs.
Our measurement metrics included true
positive, false positive, false negative, total
number of positive instances, Precision, Re-
call and F-1 score.
5.2. Results
Table 3 shows the outcomes of the exper-
iments by computing the metrics and by
training over the DDI corpus. The ta-
ble shows results for Global context ker-
nel (GCK), Subtree and shortest path ker-
nel (SubtreeK) and corresponding combined
negation methods (GCKNS = GCK with
negation features; SubtreeKNS = Subtree
kernel with negation features). The first
three rows of the table show the performance
of the three basic kernels and the last three
ones (with NS postfix) show the outcomes for
the combined version that includes negation
features. The best result was obtained with
GCKNS, and the worst result was obtained
by the shortest path tree approach. More-
over, the best improvement was obtained
by the GCK approach; it improves 3.8 per-
centual points of the F score.
As we can see in the table, there is an
improved performance when we applied the
negation features for classification. This fact
Behrouz Bokharaeian, Alberto Díaz y Miguel Ballesteros
54
Method TP FP FN Total P R F1
GCK: 902 1094 1500 2402 0.452 0.376 0.410
SubtreeK: 818 1105 1584 2402 0.425 0.341 0.378
ShortestPathTK: 795 1066 1607 2402 0.427 0.331 0.373
GCKNS: 987 1021 1415 2402 0.492 0.411 0.448
SubtreeKNS: 919 1280 1483 2402 0.418 0.383 0.399
ShortestPathTKNS: 936 1240 1466 2402 0.430 0.390 0.409
Table 3: 10- cross validation results for the methods that do not use negation features and the
methods that use negation features.
demonstrates our hypothesis and the empha-
sizes the purpose of the present work.
6. Conclusions and Future Work
Due to the huge amount of drug related in-
formation in bio-medical documents and the
importance of detecting dangerous drug-drug
interactions in medical treatments, we believe
that implementing automatic Drug-Drug in-
teraction extraction methods from text is
critical. The DrugDDI corpus is the first
annotated corpus for Dug-Drug interaction
tasks used in the DDI Extraction 2011 chal-
lenge.
In this paper, after reviewing related
work on biomedical relation extraction, we
first explained the process of annotating the
DrugDDI corpus with negation tags; and
then we explored the performance of combing
negation features with three simple relation
extraction methods. Our results show the su-
perior performance of the combined method
utilizing negation features over the three ba-
sic experimented relation extraction meth-
ods.
However, the experiments also show that
the application of negation features can in-
deed improve the relation extraction perfor-
mance but the obtained improvement clearly
depends on the number and rate of positive
and negative relations, rate of negative cues
in the corpus, and other relation extraction
features. It is also true that combining nega-
tion features with a huge number of other fea-
tures may not improve the performance and
even may hurt the final result, and this is
why we used a limited number of features.
It is therefore obvious that corpora having
more sentences with negation cues can bene-
fit more from using negation features.
For further work, we plan to use a different
type of annotation such as negation events
instead of scopes, and also handling hedge
cues and speculative statements in conjunc-
tion with negations.
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